Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06537076RecruitingPhase 2
Testing AR1005 for Lewy body dementia
This trial tests an experimental oral medication called AR1005 for people with Lewy body dementia or its early stage. It aims to see if the drug is safe and helps with memory, thinking, and daily function.
SeoulAges 60 years+ - NCT06537219Recruiting
Fascia stiffness and pain in young adults with chronic back pain
This study looks at how stiffness in the connective tissue (fascia) of the lower back relates to pain in young people with chronic low back pain. It may help find new ways to treat this common problem.
AnkaraAges 18–50 - NCT06537583Recruiting
Ear stimulation after a STEMI heart attack
This study tests whether gentle electrical stimulation near your ear (tragus) can help stabilize your heart's rhythm and reduce inflammation after a STEMI heart attack. It may help lower the risk of future heart problems.
Semarang, Central of JavaAges 18–70 - NCT06537700Recruiting
Testing Botox for Chronic Migraine: Does Timing Matter?
This study tests how well Botox works for chronic migraine patients, depending on how long they've had the condition. If you have chronic migraines, haven't had Botox recently, and meet a few other conditions, you may be able to join.
AnconaAges 18–70 - NCT06538155Recruiting
Using smartwatch data to predict cardiac arrest
This trial uses data from smartwatches and smartphones to better predict and recognize cardiac arrest. If you are a healthy volunteer or have had a heart event, your device data could help improve emergency care.
MilanAges 18 years+ - NCT06537752Recruiting
Study on symptoms of ethanol in breast cancer patients
This trial checks how breast cancer patients react to ethanol (alcohol) during chemotherapy with docetaxel. It aims to understand side effects and safety for people getting this treatment.
SeoulAges 19 years+ - NCT06537908Recruiting
Check if a new drug combo works for advanced liver cancer
This trial tests a combination of immunotherapy (anti-PD-1/PD-L1) and an anti-VEGF drug for people with advanced hepatocellular carcinoma (HCC), a type of liver cancer that cannot be removed by surgery or has spread. The goal is to see if these drugs can shrink tumors or slow the cancer's growth.
ShanghaiAges 18–90 - NCT06538038Recruiting
Osimertinib plus chemo vs. osimertinib alone for EGFR-mutated NSCLC
This study compares two standard treatments for advanced lung cancer with an EGFR mutation: osimertinib alone versus osimertinib plus chemotherapy. It aims to see which approach works better and is not a trial of a new drug, so you can receive usual care while contributing data.
Birmingham, AlabamaAges 18 years+ - NCT06538077RecruitingPhase 4
BCAA vs. Rifaximin to Prevent Recurrent Hepatic Encephalopathy
This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.
ChandigarhAges 18–65 - NCT06538220Recruiting
A study on care for obese patients in a chronic disease unit
This study looks at how well a special care program works for people with obesity. It aims to improve health and quality of life through a dedicated chronic disease unit.
La Garde, VarAges 18 years+ - NCT06538558RecruitingPhase 1
Study of tezampanel for opioid withdrawal
This trial tests if tezampanel can help relieve withdrawal symptoms in people with opioid use disorder who are seeking treatment. Participants must already be in an outpatient addiction program.
Indianapolis, IndianaAges 18–65 - NCT06538948Recruiting
Eating behavior after weight loss surgery
This study measures how people eat and how their gut hormones change after weight loss surgery. It compares different groups to understand differences between men and women.
Männedorf, Canton of ZurichAges 18 years+ - NCT06539182RecruitingPhase 2
DZD8586 for relapsed or refractory CLL/SLL
This trial tests a new oral drug called DZD8586 for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to previous treatment. The goal is to see if it can help control the disease.
Hefei, AnhuiAges 18 years+ - NCT06539520Recruiting
Walking exercise for heart and lung health after stroke
This trial tests whether a supervised walking and exercise program can improve your heart and lung fitness and overall quality of life after a stroke. It is designed for people who are still affected by weakness on one side but can walk on their own.
GizaAges 55–65 - NCT06539793Recruiting
Nerve stimulation for fibromyalgia pain
This trial tests if a gentle nerve stimulation treatment can reduce pain and improve daily function in people with fibromyalgia. It aims to understand how treatment affects natural pain signals.
Sadat, MenoufiaAges 25–35 - NCT06539637RecruitingEarly Phase 1
Ketorolac levels in eye fluid during cataract and vitrectomy surgery
This study looks at how much of the drug ketorolac (a pain and inflammation medicine) gets into the fluid inside your eye when it's given as eye drops during combined cataract and vitrectomy surgery. It may help doctors understand if using another drug called phenylephrine alongside it changes those levels.
Westbury, New YorkAges 18 years+ - NCT06539832Recruiting
Gut bacteria and immunity in people with an abnormal blood protein
This study looks at how your gut bacteria (intestinal flora) and immune system relate to a condition called monoclonal gammopathy, where an abnormal protein is found in the blood. The trial will check samples from your blood, plasma, and stool to understand these connections.
Guanzhou, GuangdongAges 45 years+ - NCT06539988Recruiting
Helping veterans choose their care appointments
This study helps Veterans decide which type of appointment (in-person, phone, or video) works best for them. You'll get text messages to support your choices and see if these messages help you get the care you need.
Ann Arbor, MichiganAges 18 years+ - NCT06540495Recruiting
Virtual exercise program for lung cancer patients
This trial tests a personalized exercise program you can do from home using a computer or tablet. It’s for people with non-small cell lung cancer at different stages of treatment, and aims to help improve strength and well-being.
New Hyde Park, New YorkAges 18 years+ - NCT06540690Recruiting
Healing after gum graft surgery: diabetic vs non-diabetic
This study looks at how well the roof of the mouth heals after a small piece is taken for a gum graft. It compares healing in people with type 2 diabetes to healing in people without diabetes. The goal is to see if diabetes affects recovery.
São José dos Campos, São PauloAges 18–80 - NCT06541067RecruitingPhase 2
Posaconazole to prevent fungal infections after stem cell transplant
This trial tests whether the antifungal drug posaconazole can prevent serious fungal infections in people who are at high risk after a stem cell transplant. If you qualify, you would take posaconazole during your recovery.
Nantes, FranceAges 18 years+ - NCT06541509RecruitingPhase 1/Phase 2
Semaglutide for heart failure in overweight patients
This trial studies whether the drug semaglutide can help people with heart failure who are overweight. It aims to see if the drug improves heart function and symptoms.
Palo Alto, CaliforniaAges 20–80 - NCT06541847RecruitingPhase 2
Testing HLX-1502 for NF1 with Plexiform Neurofibromas
This trial tests an experimental drug called HLX-1502 for people with NF1 who have a plexiform neurofibroma (a type of nerve tumor) that is growing or causing problems. It aims to see if the drug is safe and can shrink or stop the tumor from worsening.
Birmingham, AlabamaAges 12 years+ - NCT06541990Recruiting
Learning program for liver cancer patients
This study tests a psychoeducational program to help patients with newly diagnosed liver cancer (HCC) learn about their condition and cope better. It aims to see if this support improves well-being.
Boston, MassachusettsAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.